Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
Knot good: How cells untie DNA to protect the genome
Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such structure, the G-quadruplex (G4), looks like a knot. These knots can play important roles in turning genes on or off. But if not untangled in time, they can harm our genome. Now, researchers from the Knipscheer Group, in collaboration with the Karolinska Institutet, have uncovered a surprising mechanism that keeps these knots in check. Their work, published in Science on June 12th, could lead to new ways to treat diseases like cancer.
Number of animal experiments at Utrecht University and UMC Utrecht declines further in 2024
The number of animal experiments conducted by Utrecht University and UMC Utrecht has declined again over the past year. The numbers dropped from 14,192 in 2023 to 12,584 in 2024. This is evident from the joint 2024 Annual Report on Animal Experiments.
Utrecht Life Sciences: from pitch to practise
On 1st October 2024, Professor Paul Coffer stepped into his role as Scientific Director of Utrecht University’s Strategic Theme Life Sciences. More than six months in, the honeymoon period is over and the course ahead is clear. What did he encounter, and where is he heading next?
Record number of participants cross the finish line at the sunny Utrecht Science Park during the HiPRO Utrecht Marathon
On Sunday 18 May, Utrecht was all about sports. The HiPRO Utrecht Marathon experienced a special edition with a full lap at the marathon distance and a record number of participants of over 18,500. In the morning, thousands of runners started their run. Traditionally, the start and finish took place at the Utrecht Science Park, which was the vibrant heart of this sports event.